Endovascular Abdominal Aorta with Iliac Branch Procedures DRG Reimbursement

Trials comparing different endovascular device designs and deployment techniques for complex abdominal aortic aneurysms with iliac branch involvement, focusing on procedural success, need for adjunctive maneuvers, and early perioperative complications. These studies enroll patients presenting for elective or urgent endovascular repair of abdominal aortic aneurysms extending into the common or internal iliac arteries, often with challenging anatomy such as tortuosity or short landing zones; they evaluate technical feasibility and intraoperative metrics like contrast use and fluoroscopy time. Results inform procedural planning, device selection, and resource utilization that directly impact hospital costs, length of stay, and coding for this DRG, so payers and providers benefit from evidence guiding efficient, safe interventions.
Comparative effectiveness trials assessing endovascular iliac branch preservation strategies versus hybrid or open reconstruction in high‑risk surgical candidates, measuring midterm patency, limb ischemia prevention, reintervention rates, and quality of life. These studies target older patients with comorbidities (cardiopulmonary disease, renal impairment) for whom the balance between minimally invasive therapy and durability is critical; they often stratify by anatomical complexity and perioperative risk. Findings are relevant to discharge planning and downstream costs, as differences in reintervention frequency and complication profiles influence readmissions, long‑term surveillance needs, and overall payer expenditures associated with DRG 213.
Post‑discharge and device‑surveillance cohort studies that monitor long‑term outcomes such as endoleak incidence, graft migration, iliac limb occlusion, and secondary interventions, as well as patient‑reported outcomes and cost‑effectiveness of surveillance protocols. These observational studies follow patients treated with iliac branch endografts to define optimal imaging intervals, identify predictors of late failure, and quantify cumulative resource use over years after the index hospitalization. For providers and payers, this research clarifies the expected longitudinal burden of care, informs follow‑up regimens that balance early detection with cost containment, and supports reimbursement and coverage decisions tied to durable performance of endovascular repairs.

Trials comparing different endovascular device designs and deployment techniques for complex abdominal aortic aneurysms with iliac branch involvement, focusing on procedural success, need for adjunctive maneuvers, and early perioperative complications. These studies enroll patients presenting for elective or urgent endovascular repair of abdominal aortic aneurysms extending into the common or internal iliac arteries, often with challenging anatomy such as tortuosity or short landing zones; they evaluate technical feasibility and intraoperative metrics like contrast use and fluoroscopy time. Results inform procedural planning, device selection, and resource utilization that directly impact hospital costs, length of stay, and coding for this DRG, so payers and providers benefit from evidence guiding efficient, safe interventions.
Comparative effectiveness trials assessing endovascular iliac branch preservation strategies versus hybrid or open reconstruction in high‑risk surgical candidates, measuring midterm patency, limb ischemia prevention, reintervention rates, and quality of life. These studies target older patients with comorbidities (cardiopulmonary disease, renal impairment) for whom the balance between minimally invasive therapy and durability is critical; they often stratify by anatomical complexity and perioperative risk. Findings are relevant to discharge planning and downstream costs, as differences in reintervention frequency and complication profiles influence readmissions, long‑term surveillance needs, and overall payer expenditures associated with DRG 213.
Post‑discharge and device‑surveillance cohort studies that monitor long‑term outcomes such as endoleak incidence, graft migration, iliac limb occlusion, and secondary interventions, as well as patient‑reported outcomes and cost‑effectiveness of surveillance protocols. These observational studies follow patients treated with iliac branch endografts to define optimal imaging intervals, identify predictors of late failure, and quantify cumulative resource use over years after the index hospitalization. For providers and payers, this research clarifies the expected longitudinal burden of care, informs follow‑up regimens that balance early detection with cost containment, and supports reimbursement and coverage decisions tied to durable performance of endovascular repairs.

OpenPayer

Summary & Overview

Endovascular Abdominal Aorta with Iliac Branch Procedures: Inpatient Reimbursement Overview

DRG 213 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes